KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Inventory Average (2016 - 2024)

Nektar Therapeutics has reported Inventory Average over the past 14 years, most recently at $15.4 million for Q2 2024.

  • Quarterly results put Inventory Average at $15.4 million for Q2 2024, down 24.98% from a year ago — trailing twelve months through Jun 2024 was $15.4 million (down 24.98% YoY), and the annual figure for FY2023 was $17.7 million, up 0.86%.
  • Inventory Average for Q2 2024 was $15.4 million at Nektar Therapeutics, down from $16.2 million in the prior quarter.
  • Over the last five years, Inventory Average for NKTR hit a ceiling of $20.5 million in Q2 2023 and a floor of $12.7 million in Q3 2020.
  • Median Inventory Average over the past 5 years was $15.7 million (2021), compared with a mean of $16.1 million.
  • Biggest five-year swings in Inventory Average: increased 26.51% in 2023 and later dropped 24.98% in 2024.
  • Nektar Therapeutics' Inventory Average stood at $14.1 million in 2020, then increased by 10.46% to $15.6 million in 2021, then rose by 22.9% to $19.1 million in 2022, then fell by 18.37% to $15.6 million in 2023, then decreased by 1.69% to $15.4 million in 2024.
  • The last three reported values for Inventory Average were $15.4 million (Q2 2024), $16.2 million (Q1 2024), and $15.6 million (Q4 2023) per Business Quant data.